Department of Gastroenterology and Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Hepatol Res. 2010 Nov;40(11):1092-7. doi: 10.1111/j.1872-034X.2010.00707.x. Epub 2010 Sep 28.
Liver dysfunction is not rare in patients with collagen disease. We sought to elucidate the clinical features of liver dysfunction in the presence of collagen disease.
We analyzed the frequency and causes of liver dysfunction in 607 patients (rheumatoid arthritis [RA], n = 220; systemic lupus erythematosus [SLE], n = 164; systemic sclerosis [SSc], n = 47; Sjögren's syndrome [SjS], n = 44; Behçet's disease, n = 43; polymyositis/dermatomyositis [PM/DM], n = 27; vasculitis syndrome, n = 25; mixed connective tissue disease [MCTD], n = 21; and adult-onset Still's disease [AOSD], n = 16).
Liver dysfunction was observed in 238 (39.2%) of 607 patients showing collagen disease. Patients with AOSD (81.3%), PM/DM (51.9%) and vasculitis syndrome (48.0%) frequently displayed liver dysfunction. Liver dysfunction in collagen diseases results from many causes; drug-induced liver injury (26.1%), fatty liver (7.6%), viral hepatitis (1.3%), autoimmune hepatitis (4.2%), primary biliary cirrhosis (15.9%) and the collagen disease itself (15.5%). Conversely, primary biliary cirrhosis was a leading cause in SSc (76.1%) and SjS (70.0%). Liver dysfunction in collagen disease tended to be mild. In addition, alanine aminotransferase levels correlated positively with ferritin levels in AOSD (R = 0.708, P < 0.05). Moreover, alkaline phosphatase levels correlated positively with C reactive protein levels in vasculitis syndrome (R = 0.833, P < 0.05).
Liver dysfunction in the presence of collagen disease has various causes, and dysfunction associated with collagen disease reflects the activity of the collagen disease itself.
肝功能障碍在胶原病患者中并不罕见。我们旨在阐明胶原病患者肝功能障碍的临床特征。
我们分析了 607 例患者(类风湿关节炎[RA],n=220;系统性红斑狼疮[SLE],n=164;系统性硬皮病[SSc],n=47;干燥综合征[SjS],n=44;贝赫切特病,n=43;多发性肌炎/皮肌炎[PM/DM],n=27;血管炎综合征,n=25;混合性结缔组织病[MCTD],n=21;成人Still 病[AOSD],n=16)中肝功能障碍的频率和原因。
607 例胶原病患者中有 238 例(39.2%)出现肝功能障碍。AOSD(81.3%)、PM/DM(51.9%)和血管炎综合征(48.0%)患者常出现肝功能障碍。胶原病相关肝损伤的原因很多,包括药物性肝损伤(26.1%)、脂肪肝(7.6%)、病毒性肝炎(1.3%)、自身免疫性肝炎(4.2%)、原发性胆汁性肝硬化(15.9%)和胶原病本身(15.5%)。相反,原发性胆汁性肝硬化是 SSc(76.1%)和 SjS(70.0%)的主要原因。胶原病相关肝功能障碍往往较轻。此外,AOSD 中丙氨酸氨基转移酶水平与铁蛋白水平呈正相关(R=0.708,P<0.05)。此外,血管炎综合征中碱性磷酸酶水平与 C 反应蛋白水平呈正相关(R=0.833,P<0.05)。
胶原病患者肝功能障碍的原因多种多样,与胶原病相关的肝功能障碍反映了胶原病本身的活动。